Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts (Q43042854)
Jump to navigation
Jump to search
scientific article published in August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts |
scientific article published in August 2010 |
Statements
1 reference
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts (English)
1 reference
Wah-Seng Lim
1 reference
Paul G Tardi
1 reference
Xiaowei Xie
1 reference
Mannie Fan
1 reference
Ruby Huang
1 reference
Travis Ciofani
1 reference
Troy O Harasym
1 reference
Lawrence D Mayer
1 reference
1 August 2010
1 reference
1 reference
51
1 reference
8
1 reference
1536-1542
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference